Australia markets open in 6 hours 7 minutes

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.01+0.01 (+0.10%)
As of 01:49PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-6,303
-2,494
-78.292
-1,022
Depreciation & amortisation
2,646
2,488
2,461
2,347
Deferred income taxes
-
-
0
-14.631
Stock-based compensation
333.602
266.244
144.313
253.135
Change in working capital
-2,071
-1,833
-1,623
532.261
Accounts receivable
-162.755
935.629
-897.428
-159.636
Inventory
-2,068
-2,949
-997.46
425.742
Other working capital
-8,550
-5,519
-1,654
-2,757
Other non-cash items
132.794
36.134
18.557
118.044
Net cash provided by operating activities
-5,249
-1,544
954.17
1,316
Cash flows from investing activities
Investments in property, plant and equipment
-3,301
-3,975
-2,609
-4,073
Acquisitions, net
-
-
-
0
Purchases of investments
-
-
0
-1,992
Sales/maturities of investments
-
0
996
3,449
Other investing activities
-
-
15.29
45.6
Net cash used for investing activities
-3,414
-3,964
-1,597
-2,570
Cash flows from financing activities
Debt repayment
-3,140
-897.125
-768.271
-9,574
Common stock issued
-
0
4,233
0
Other financing activities
-35.425
-19.306
2.272
-53.136
Net cash used provided by (used for) financing activities
1,825
1,114
3,879
1,911
Net change in cash
-6,838
-4,394
3,236
656.644
Cash at beginning of period
8,828
10,185
6,950
6,293
Cash at end of period
1,989
5,792
10,185
6,950
Free cash flow
Operating cash flow
-5,249
-1,544
954.17
1,316
Capital expenditure
-3,301
-3,975
-2,609
-4,073
Free cash flow
-8,550
-5,519
-1,654
-2,757